Literature DB >> 27045189

Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings.

Rolf H H Groenwold1, Karel G M Moons2, Romin Pajouheshnia3, Doug G Altman4, Gary S Collins4, Thomas P A Debray2, Johannes B Reitsma2, Richard D Riley5, Linda M Peelen3.   

Abstract

OBJECTIVES: To compare different methods to handle treatment when developing a prognostic model that aims to produce accurate probabilities of the outcome of individuals if left untreated. STUDY DESIGN AND
SETTING: Simulations were performed based on two normally distributed predictors, a binary outcome, and a binary treatment, mimicking a randomized trial or an observational study. Comparison was made between simply ignoring treatment (SIT), restricting the analytical data set to untreated individuals (AUT), inverse probability weighting (IPW), and explicit modeling of treatment (MT). Methods were compared in terms of predictive performance of the model and the proportion of incorrect treatment decisions.
RESULTS: Omitting a genuine predictor of the outcome from the prognostic model decreased model performance, in both an observational study and a randomized trial. In randomized trials, the proportion of incorrect treatment decisions was smaller when applying AUT or MT, compared to SIT and IPW. In observational studies, MT was superior to all other methods regarding the proportion of incorrect treatment decisions.
CONCLUSION: If a prognostic model aims to produce correct probabilities of the outcome in the absence of treatment, ignoring treatments that affect that outcome can lead to suboptimal model performance and incorrect treatment decisions. Explicitly, modeling treatment is recommended.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  Calibration; Computer simulation; Decision support techniques; Models; Prognosis; Statistical

Mesh:

Year:  2016        PMID: 27045189     DOI: 10.1016/j.jclinepi.2016.03.017

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  20 in total

Review 1.  Pre-procedural risk models for patients undergoing transcatheter aortic valve implantation.

Authors:  Glen P Martin; Matthew Sperrin; Mamas A Mamas
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

2.  A study protocol for the development of a multivariable model predicting 6- and 12-month mortality for people with dementia living in residential aged care facilities (RACFs) in Australia.

Authors:  Ross Bicknell; Wen Kwang Lim; Andrea B Maier; Dina LoGiudice
Journal:  Diagn Progn Res       Date:  2020-10-07

3.  Prognostic models for amyotrophic lateral sclerosis: a systematic review.

Authors:  Lu Xu; Bingjie He; Yunjing Zhang; Lu Chen; Dongsheng Fan; Siyan Zhan; Shengfeng Wang
Journal:  J Neurol       Date:  2021-03-10       Impact factor: 4.849

4.  Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.

Authors:  Marc Lipman; Mahdad Noursadeghi; Ibrahim Abubakar; Rishi K Gupta; Claire J Calderwood; Alexei Yavlinsky; Maria Krutikov; Matteo Quartagno; Maximilian C Aichelburg; Neus Altet; Roland Diel; Claudia C Dobler; Jose Dominguez; Joseph S Doyle; Connie Erkens; Steffen Geis; Pranabashis Haldar; Anja M Hauri; Thomas Hermansen; James C Johnston; Christoph Lange; Berit Lange; Frank van Leth; Laura Muñoz; Christine Roder; Kamila Romanowski; David Roth; Martina Sester; Rosa Sloot; Giovanni Sotgiu; Gerrit Woltmann; Takashi Yoshiyama; Jean-Pierre Zellweger; Dominik Zenner; Robert W Aldridge; Andrew Copas; Molebogeng X Rangaka
Journal:  Nat Med       Date:  2020-10-19       Impact factor: 53.440

5.  The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial.

Authors:  Meron M Kifle; Prabin Dahal; Manu Vatish; Ana Sofia Cerdeira; Eric O Ohuma
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-27       Impact factor: 3.105

6.  The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.

Authors:  David M Kent; David van Klaveren; Jessica K Paulus; Ralph D'Agostino; Steve Goodman; Rodney Hayward; John P A Ioannidis; Bray Patrick-Lake; Sally Morton; Michael Pencina; Gowri Raman; Joseph S Ross; Harry P Selker; Ravi Varadhan; Andrew Vickers; John B Wong; Ewout W Steyerberg
Journal:  Ann Intern Med       Date:  2019-11-12       Impact factor: 25.391

7.  Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment.

Authors:  Zhe Xu; Matthew Arnold; David Stevens; Stephen Kaptoge; Lisa Pennells; Michael J Sweeting; Jessica Barrett; Emanuele Di Angelantonio; Angela M Wood
Journal:  Am J Epidemiol       Date:  2021-10-01       Impact factor: 5.363

8.  Accounting for treatment use when validating a prognostic model: a simulation study.

Authors:  Romin Pajouheshnia; Linda M Peelen; Karel G M Moons; Johannes B Reitsma; Rolf H H Groenwold
Journal:  BMC Med Res Methodol       Date:  2017-07-14       Impact factor: 4.615

9.  The development and validation of a prognostic model to PREDICT Relapse of depression in adult patients in primary care: protocol for the PREDICTR study.

Authors:  Andrew S Moriarty; Lewis W Paton; Kym I E Snell; Richard D Riley; Joshua E J Buckman; Simon Gilbody; Carolyn A Chew-Graham; Shehzad Ali; Stephen Pilling; Nick Meader; Bob Phillips; Peter A Coventry; Jaime Delgadillo; David A Richards; Chris Salisbury; Dean McMillan
Journal:  Diagn Progn Res       Date:  2021-07-02

Review 10.  Algorithmic prognostication in critical care: a promising but unproven technology for supporting difficult decisions.

Authors:  Gary E Weissman; Vincent X Liu
Journal:  Curr Opin Crit Care       Date:  2021-10-01       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.